These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26036531)

  • 1. Pre- and Posttransplant IgA Anti-Fab Antibodies to Predict Long-term Kidney Graft Survival.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Solgi G
    Transplant Proc; 2015 May; 47(4):1110-3. PubMed ID: 26036531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early post-transplant immune monitoring can predict long-term kidney graft survival: soluble CD30 levels, anti-HLA antibodies and IgA-anti-Fab autoantibodies.
    Amirzargar MA; Amirzargar A; Basiri A; Hajilooi M; Roshanaei G; Rajabi G; Mohammadiazar S; Solgi G
    Hum Immunol; 2014 Jan; 75(1):47-58. PubMed ID: 24055694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity as prognostic indicators of kidney graft survival.
    Süsal C; Dörr C; Groth J; May G; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S586-9. PubMed ID: 11271315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK
    Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-protective role of high pretransplantation IgA-anti-Fab autoantibodies: confirmatory evidence obtained in more than 4000 kidney transplants. The Collaborative Transplant Study.
    Süsal C; Döhler B; Opelz G
    Transplantation; 2000 Apr; 69(7):1337-40. PubMed ID: 10798750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA.
    Solgi G; Furst D; Mytilineos J; Pourmand G; Amirzargar AA
    Transpl Immunol; 2012 Mar; 26(2-3):81-7. PubMed ID: 22182633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgA class antibodies and flow cytometric cross-matching in renal transplantation.
    Doran TJ; Süsal C; Opelz G; Geczy AF
    Transplantation; 1999 Jan; 67(2):309-14. PubMed ID: 10075600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss.
    Lee PC; Zhu L; Terasaki PI; Everly MJ
    Transplantation; 2009 Aug; 88(4):568-74. PubMed ID: 19696641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of protective anti-Fab autoantibodies in kidney graft recipients.
    Süsal C; Groth J; Tanzi-Fetta RF; Kirste G; Doerr C; Terness P; May G; Staehler G; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2523-6. PubMed ID: 1465853
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretransplant IgA-anti-hinge and IgA-anti-Fab autoantibody activity is associated with good kidney graft survival.
    Süsal C; Kröpelin M; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Oct; 27(5):2663-5. PubMed ID: 7482869
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretransplant serum IgA concentration and IgA-anti-Fab autoantibody activity in living donor renal transplant recipients: a pilot study.
    Kim MS; Kim YS; Kim SI; Lee JW; Moon JI; Park K
    Transplant Proc; 1998 Nov; 30(7):2977-8. PubMed ID: 9838314
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HLA antibodies and kidney allograft outcomes in recipients with donor bone marrow cell infusion.
    Solgi G; Pourmand G; Mehrsai A; Taherimahmoudi M; Nicknam MH; Ebrahimi Rad MR; Seraji A; Asadpoor A; Ansaripor B; Nikbin B; Amirzargar A
    Iran J Immunol; 2010 Mar; 7(1):18-29. PubMed ID: 20371916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional assessment of immune markers of graft rejection: a comprehensive study in live-related donor renal transplantation.
    Panigrahi A; Deka R; Bhowmik D; Dash SC; Tiwari SC; Guleria S; Mehta SN; Mehra NK
    Clin Transplant; 2006; 20(1):85-90. PubMed ID: 16556160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent kidney graft survival in patients with high pretransplant serum IgA concentrations and IgA-anti-Fab autoantibody activity.
    Süsal C; Wiesel M; Staehler G; Groth J; May G; Opelz G
    Transplant Proc; 1995 Feb; 27(1):1072-4. PubMed ID: 7878810
    [No Abstract]   [Full Text] [Related]  

  • 20. Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies.
    Regan J; Monteiro F; Speiser D; Kalil J; Pouletty P; Buelow R
    Am J Kidney Dis; 1996 Jul; 28(1):92-8. PubMed ID: 8712228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.